Company registration number 08220446 (England and Wales)
DAVIS SCIENTIFIC TREATMENTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
DAVIS SCIENTIFIC TREATMENTS LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet and notes to the financial statements
2 - 3
DAVIS SCIENTIFIC TREATMENTS LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF DAVIS SCIENTIFIC TREATMENTS LIMITED FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Davis Scientific Treatments Limited for the year ended 30 September 2025, which comprise the balance sheet, from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the b oard of d irectors of Davis Scientific Treatments Limited, as a body, in accordance with the terms of our engagement letter dated 8 December 2014. Our work has been undertaken solely to prepare for your approval the financial statements of Davis Scientific Treatments Limited and state those matters that we have agreed to state to the b oard of d irectors of Davis Scientific Treatments Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Davis Scientific Treatments Limited and its b oard of d irectors as a body, for our work or for this report.

It is your duty to ensure that Davis Scientific Treatments Limited has kept adequate accounting records and to prepare statutory financial statements that comply with the requirements of the Companies Act 2006. You consider that Davis Scientific Treatments Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Davis Scientific Treatments Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory f inancial statements.

Griffiths Marshall Business Advisory Limited
Chartered Accountants
4th Floor
Llanthony Warehouse
The Docks
Gloucester
Gloucestershire
GL1 2EH
United Kingdom
14 April 2026
DAVIS SCIENTIFIC TREATMENTS LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 2 -
2025
2024
£
£
£
£
Fixed assets
67,977
78,554
Current assets
206,534
167,129
Prepayments and accrued income
6,730
6,210
Creditors: amounts falling due within one year
(54,047)
(42,839)
Net current assets
159,217
130,500
Total assets less current liabilities
227,194
209,054
Creditors: amounts falling due after more than one year
(20,302)
(25,891)
Accruals and deferred income
(10,664)
(8,337)
Net assets
196,228
174,826
Capital and reserves
196,228
174,826
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year wa s as follows:

2025
2024
Number
Number
Employees
5
5

Davis Scientific Treatments Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 5D, Delta Drive,, Tewkesbury Industrial Estate, Ashchurch, Tewkesbury, Gloucestershire, GL20 8HB.

For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

DAVIS SCIENTIFIC TREATMENTS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 SEPTEMBER 2025
30 September 2025
- 3 -
The financial statements were approved by the board of directors and authorised for issue on 14 April 2026 and are signed on its behalf by:
R D R Andrews
Director
Company Registration Number 08220446
DAVIS SCIENTIFIC TREATMENTS LIMITED
- 4 -
The following pages do not form part of the statutory accounts
2025-09-30 2024-10-01 false false CCH Software CCH Accounts Production 2025.200 No description of principal activity R D R Andrews M C Andrews G L Francis P J Francis A Williamson N J Williamson false 08220446 2024-10-01 2025-09-30 08220446 2025-09-30 08220446 2024-09-30 08220446 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 08220446 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 08220446 core:Non-currentFinancialInstruments 2025-09-30 08220446 core:Non-currentFinancialInstruments 2024-09-30 08220446 2023-10-01 2024-09-30 08220446 bus:Director1 2024-10-01 2025-09-30 08220446 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 08220446 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 08220446 bus:Micro-entities 2024-10-01 2025-09-30 08220446 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 08220446 bus:Director2 2024-10-01 2025-09-30 08220446 bus:Director3 2024-10-01 2025-09-30 08220446 bus:Director4 2024-10-01 2025-09-30 08220446 bus:Director5 2024-10-01 2025-09-30 08220446 bus:Director6 2024-10-01 2025-09-30 08220446 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP